The short answer: GLP-1 medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are widely used by women in midlife, and while most of the conversation is about the weight coming off, the part that matters specifically in menopause is what they do to muscle and bone in a body that is already losing both. A meaningful share of the weight lost on these drugs, often cited in the region of a quarter to two-fifths, can come from lean tissue rather than fat, and menopause already accelerates the loss of muscle and bone as estrogen (oestrogen) declines. Layering one on the other is what has led clinicians to describe a possible “perfect storm” for bone loss. This is not a reason to rule the medications out; the evidence is still developing and they have real benefits. It is a reason to protect muscle and bone actively if you use one: prioritise protein, do resistance training, discuss a baseline bone scan, and work closely with your prescriber. The decision belongs with you and a qualified clinician.<\/p>\n
If the weight settled around your middle in your late forties and refused to shift no matter what you did, you are not imagining it, and you are not alone in looking at a GLP-1 medication as a way out. Drugs such as semaglutide and tirzepatide are being used by a great many women at exactly this stage of life, and reporting suggests women aged 50 to 64 are among the highest users. Most of the public conversation is about the scale going down. The part that gets far less attention, and that matters specifically for women in menopause, is what these medications do to muscle and bone during a transition that is already eroding both. This is not a reason to rule them out. It is a reason to go in informed, so the bone and muscle side of the story is not an afterthought.<\/p>\n
GLP-1 receptor agonists are prescription medications originally developed for type 2 diabetes and now also widely used for weight management. They mimic a gut hormone that helps regulate blood sugar and appetite, working partly by slowing digestion and reducing hunger, so you eat less without the constant battle of willpower that other approaches demand. They are genuine prescription treatments with their own benefits, side effects and monitoring needs, and any decision about starting, continuing or stopping one belongs with your prescriber rather than being made from general information. For many women they achieve weight loss that years of dieting did not, which is precisely why the muscle and bone question is worth getting right rather than dismissing.<\/p>\n
When you lose weight, some of what you lose is fat and some is lean tissue, meaning muscle. Studies of GLP-1 therapy indicate that a meaningful share of total weight lost can come from lean mass, with figures often cited in the region of a quarter to two-fifths of total weight lost, depending on the study, the drug and the person. That is not unique to these medications, it happens with significant weight loss generally, but the amounts involved make it relevant.<\/p>\n
Here is why it intersects so sharply with menopause. As estrogen declines, women already tend to lose muscle and bone density at an accelerated rate, with bone loss being especially rapid in the years around the final period, as our guide to bone density and menopause<\/a> explains. Layering a medication that can further reduce muscle, and that some experts warn may affect bone, on top of that natural decline is what has led clinicians to describe a potential “perfect storm” for bone loss. Public health commentators and menopause specialists have raised this specifically for menopausal women, because the two processes stack rather than simply coexist.<\/p>\n The evidence here is still developing, and the picture is not settled. The point is not that GLP-1 medications are unsafe in menopause. It is that muscle and bone deserve active, deliberate attention if you use one during this stage, rather than being left to chance.<\/p>\n None of this is medical advice for your situation, but these are the levers clinicians commonly discuss.<\/p>\n Some women are on, or considering, both HRT and a GLP-1, which is unsurprising given that both are common in midlife. There is not yet a large body of evidence on using them together specifically, so this is a conversation to have with a clinician who can see your full history rather than something to decide from general information online. It is worth noting that HRT itself supports bone density, which is part of why the interaction is worth discussing rather than guessing at. Our explainer on what HRT involves<\/a> gives the background, and how to get an HRT prescription<\/a> covers accessing it.<\/p>\n Yellow is not here to tell you whether to take a GLP-1. We are here to make sure that if you do, the bone and muscle side of the story is not an afterthought, and that you can weigh the decision with the full picture in front of you rather than only the part about the scale.<\/p>\n The long-term effect of GLP-1 medications on bone in menopausal women is not yet fully established, but some experts have raised concern because significant weight loss can reduce bone density, and menopause already accelerates bone loss. This combination has led clinicians to describe a possible “perfect storm.” It is not proof of harm, but it is a reason to discuss bone health with your prescriber if you are considering one.<\/p>\n Some experts suggest it can be reasonable, particularly because routine bone screening is often not recommended until age 65, so a woman in her early fifties may lack a baseline to compare against later. Whether a scan is right for you depends on your age, history and risk factors, so it is a decision to make with your doctor rather than a blanket rule.<\/p>\n Adequate protein helps preserve muscle during weight loss, and this can be harder when a GLP-1 suppresses appetite, so it often needs to be intentional and planned across the day. Specific targets vary by individual, body size and activity level, so ask your clinician or a dietitian for guidance suited to you rather than relying on a single number.<\/p>\n Some women use both, but there is limited evidence specifically on combining them, so this should be discussed with a clinician who knows your full medical history rather than decided from general information. HRT itself supports bone density, which is one reason the combination is worth talking through properly rather than assuming.<\/p>\n Some lean mass loss commonly accompanies significant weight loss, but resistance training and adequate protein substantially reduce how much muscle you lose and help preserve strength and function. Exercising while on a GLP-1 is one of the most effective things within your control, especially in midlife when muscle is already under pressure from declining estrogen.<\/p>\n Weight often returns after stopping unless habits are maintained, and the muscle-preserving work, resistance training and protein, matters just as much on the way through and afterwards. Planning for what happens if you stop, including how to hold onto muscle and manage weight, is a sensible part of the conversation with your prescriber from the outset.<\/p>\n This article is for general information and does not constitute medical advice, and it is not a recommendation to take or avoid any medication. GLP-1 medications are prescription treatments with individual benefits and risks. Please consult a qualified healthcare professional.<\/em><\/p>\nWhat the data does and does not show<\/h2>\n
\n
How to protect muscle and bone if you take one<\/h2>\n
\n
GLP-1 and HRT together<\/h2>\n
Questions worth asking before you start<\/h2>\n
\n
Frequently Asked Questions<\/h2>\n
Does Ozempic cause bone loss in menopause?<\/h3>\n
Should I get a bone density scan before starting a GLP-1?<\/h3>\n
How much protein do I need on a GLP-1?<\/h3>\n
Can I take HRT and a GLP-1 together?<\/h3>\n
Will I lose muscle on a GLP-1 even if I exercise?<\/h3>\n
What happens to muscle and bone if I stop the medication?<\/h3>\n
Further Reading<\/h2>\n
\n